Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Foreign body ingestions in mental disorders: What do we know and what should we do?]

Fortschritte der Neurologie-Psychiatrie·2026
Same author

The impact of a digital guideline version on schizophrenia guideline knowledge: results from a multicenter cluster-randomized controlled trial.

BMC medicine·2024
Same author

Treatment of bipolar depression: clinical practice vs. adherence to guidelines-data from a Bavarian drug surveillance project.

Frontiers in psychiatry·2024
Same author

Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study.

Translational psychiatry·2024
Same author

Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study.

Research square·2023
Same author

ICD-11 and mental disorders: important changes, controversies, and future directions.

BMC psychiatry·2023

Related Experiment Video

Updated: Jun 21, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Cognitive functioning in euthymic bipolar I and bipolar II patients.

Sandra Dittmann1, Kristina Hennig-Fast, Sonja Gerber

  • 1Department of Psychiatry and Psychotherapy, Ludwigs-Maximilians-University, Nussbaumstr. 7, Munich 80336, Germany. sandra.dittmann@med.uni-muenchen.de

Bipolar Disorders
|July 15, 2009
PubMed
Summary

Bipolar I and bipolar II disorder patients exhibit similar cognitive impairments, including deficits in psychomotor speed and executive functions. These findings suggest comparable neurocognitive profiles across bipolar disorder subtypes.

Related Experiment Videos

Last Updated: Jun 21, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Cognitive impairment is a recognized trait in bipolar disorder.
  • Previous research often focused on bipolar I disorder or mixed groups, limiting generalizability.
  • Differences in cognitive functioning between bipolar I and bipolar II disorder remain unclear.

Purpose of the Study:

  • To investigate and compare cognitive functioning in patients with bipolar I disorder, bipolar II disorder, and healthy controls.
  • To determine if distinct cognitive profiles exist between bipolar I and bipolar II disorder subtypes.
  • To assess specific domains of cognitive function, including psychomotor speed, memory, and executive functions.

Main Methods:

  • A neuropsychological battery assessed cognitive function in 65 patients with bipolar I disorder, 38 with bipolar II disorder, and 62 healthy controls.
  • All participants were euthymic for at least one month prior to assessment.
  • Univariate and multivariate analyses of variance were used to compare cognitive performance between the three groups.

Main Results:

  • Multivariate analysis revealed significant overall differences in neuropsychological performance across the groups.
  • Bipolar I patients showed deficits in psychomotor speed, working memory, verbal learning, delayed memory, and executive functions compared to controls.
  • Bipolar II patients demonstrated impairments in psychomotor speed, working memory, visual/constructional abilities, and executive functions, but not verbal learning or delayed memory.
  • Crucially, no significant differences in cognitive domains were found between bipolar I and bipolar II patient groups.

Conclusions:

  • The study supports a similar pattern of cognitive deficits in both bipolar I and bipolar II disorder subtypes.
  • Cognitive functioning appears comparably affected across the major subtypes of bipolar disorder.
  • These findings contribute to understanding the neurobiological underpinnings of bipolar disorder.